Trial Profile
Clinical Trials Insight: 700043367
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2010
Price :
$35
*
At a glance
- Drugs Adomiparin (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Momenta Pharmaceuticals
- 20 Mar 2009 Results have been published in the proceedings of the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.